Luban

Luban is a private scientific and technological company founded in 2010, focusing on the development, production, and marketing of high-quality chiral goods and fine chemicals. With a slogan of "Crafting next-gen chiral masterpieces and high-quality chemicals for the pharmaceutical industry," Luban specializes in typical pharmaceutical intermediates and essential raw materials within the Biotechnology, Health Care, and Pharmaceutical industries. The most recent investment in the company was a CNY37.60M Post-IPO Equity investment on 22 May 2017, which was contributed by Hubei Gaotou Technology Financial Investment Management, Gaorong Venture Capital, Xiaofeng Yang, and Broad Resources.